| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 |
| | S-1 | 10-K | 10-K |
| Revenues | 5.4 | 3.7 | 2.6 |
| Revenue growth | 46.4% | 38.9% | |
| Cost of goods sold | 0.0 | 1.2 | 1.5 |
| Gross profit | 5.4 | 2.5 | 1.1 |
| Gross margin | 100.0% | 68.7% | 42.6% |
| Selling, general and administrative | 12.4 | 8.3 | 6.4 |
| Research and development | 2.5 | 2.5 | 2.7 |
| Other operating expenses | 1.8 | | |
| EBITDA [+] | -11.3 | -8.3 | -8.0 |
| EBITDA growth | 36.1% | 4.1% | |
| EBITDA margin | -210.2% | -226.1% | -301.7% |
| Depreciation | 0.7 | 0.5 | 0.4 |
| EBITA | -12.0 | -8.8 | -8.4 |
| EBITA margin | -222.3% | -239.8% | -316.7% |
| Amortization of intangibles | 0.1 | 0.1 | 0.0 |
| EBIT [+] | -12.1 | -8.9 | -8.4 |
| EBIT growth | 35.9% | 5.9% | |
| EBIT margin | -224.3% | -241.7% | -317.0% |
| Interest expense | 0.0 | 0.0 | 0.2 |
| Interest expense | 0.0 | 0.0 | 0.2 |
| Other income (expense), net [+] | 0.0 | -0.1 | -2.1 |
| Impairment of investments | | | -1.0 |
| Change in fair value of warrants | 0.1 | -0.1 | |
| Other non-operating income | 0.1 | 0.1 | 0.1 |
| Other non-ooperating expenses | -0.1 | -0.2 | |
| Other | -0.1 | | |
| Pre-tax income | -12.1 | -9.1 | -10.7 |
| Income taxes | 0.0 | 0.0 | 0.0 |
| Tax rate | | 0.0% | 0.0% |
| Minority interest | | 0.0 | 0.0 |
| Net income | -12.1 | -9.1 | -10.7 |
| Net margin | -224.5% | -246.3% | -403.4% |
| |
| Basic EPS [+] | ($2.55) | ($0.48) | ($0.90) |
| Growth | 431.4% | -46.8% | |
| Diluted EPS [+] | ($2.55) | ($0.48) | ($0.90) |
| Growth | 431.4% | -46.8% | |
| |
| Shares outstanding (basic) [+] | 4.7 | 18.8 | 11.8 |
| Growth | -74.9% | 59.4% | |
| Shares outstanding (diluted) [+] | 4.7 | 18.8 | 11.8 |
| Growth | -74.9% | 59.4% | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |